Back to Search
Start Over
The selective retinoic acid receptor-α agonist AM580 fails to control autoimmune neuroinflammation.
- Source :
-
Cellular & molecular immunology [Cell Mol Immunol] 2019 Aug; Vol. 16 (8), pp. 727-729. Date of Electronic Publication: 2019 Jun 03. - Publication Year :
- 2019
- Subjects :
- Animals
Anti-Inflammatory Agents pharmacology
Benzoates pharmacology
Disease Models, Animal
Mice
Mice, Inbred C57BL
Neuroprotective Agents pharmacology
Tetrahydronaphthalenes pharmacology
Treatment Failure
Anti-Inflammatory Agents therapeutic use
Benzoates therapeutic use
Encephalomyelitis, Autoimmune, Experimental drug therapy
Neuroprotective Agents therapeutic use
Retinoic Acid Receptor alpha agonists
Tetrahydronaphthalenes therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 2042-0226
- Volume :
- 16
- Issue :
- 8
- Database :
- MEDLINE
- Journal :
- Cellular & molecular immunology
- Publication Type :
- Report
- Accession number :
- 31160758
- Full Text :
- https://doi.org/10.1038/s41423-019-0238-9